Ibionext

BrainEver is a biotech company developing treatments for neurodegenerative diseases.

Chronolife develops connected medical clothing for remote patient health monitoring and prediction.

GML designed the world’s first edge AI processor using bio-inspired architectures for low-latency, energy-efficient industrial vision and sensor data analysis.

Prophesee’s neuromorphic vision systems mimic the human eye and brain, using event-based sensors to reduce power, latency, and data processing demands.

Funding supports Gecko Biomedical’s expansion of its biopolymers platform for clinical development and approval in tissue reconstruction.

GenSight Biologics is a biopharmaceutical company specializing in discovering and developing therapies for retinal diseases.

GenSight Biologics is a clinical-stage biotech company developing gene therapies for retinal diseases.

The company’s team manages private equity investments, structuring and negotiating transactions to maximize returns for investors and create value for its portfolio companies.

iBionext is a company builder focused on creating, developing, and funding health tech start-ups at the intersection of scientific disciplines.

iBionext Growth Fund was established in 2016 to finance the growth of new start-ups in health technology.

iBionext is a start-up studio and investment fund specializing in health tech start-ups at the intersection of scientific disciplines.